Sysmex
Bookmark
ShareCopied to clipboardSysmex is a company. It is a public company in Kobe, Japan. It was founded in 1968 and its current CEO is Kaoru Asano. It is part of the Health Care sector, specifically in the Health Care Equipment & Supplies industry.
Key facts
- city: Kobe
- country: Japan
- employees: 10,042 people
- revenues: 3.4B $
- company type: public
- sector: Health Care
- industry: Health Care Equipment & Supplies
- foundation year: 1968
- CEO: Kaoru Asano
- CEO approval: 84 %
- ESG score: Try Pro to see estimate
See more facts
Extract data
Download datasets about Sysmex:
Dataset of stocks from Sysmex:
Sysmex is one of the companies in Japan, companies in Health Care Equipment & Supplies, companies in Health Care, companies in Kobe and 3,456,808 companies in our database.
Talking Points
- シスメックス株式会社 | Sysmex
- シスメックス株式会社は、「より良いヘルスケアジャーニーを、ともに。」を長期ビジョンに掲げ、臨床検査機器、試薬、ソフトウェアを世界中へお届けしています。
- シスメックス株式会社の公式アカウントです。 革新的な検査・診断技術を創出し、医療により確かな安心をお届けすることで価値の高い検査・診断を提供し、医療課題解決と持続可能な社会の実現に貢献する、当社の取り組みを紹介します。 ソーシャルメディアポリシー：https://t.co/IfwdLcSy1Y
- Lighting the way with diagnostics | Sysmex is an integrated company, developing and manufacturing the instruments, reagents, and software needed for in vitro diagnostics and providing sales and support services to more than 190 countries and regions worldwide. By creating innovative testing and diagnostic technologies to bring greater trust ...
- Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. The company offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. It also provides urine formed sediment analysis systems; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS. In addition, the company offers cancer lymph node metastasis testing systems to detect information to help in diagnosing lymph node metastasis; cancer genome profiling systems; and cytogenic testing and lab assay services. It is also involved in the development and sale of software for diagnostic information systems; provision of facility management, office, and welfare services; development, manufacture, and sale of nucleic acid analogs; development, operation, and maintenance of IT solutions, platforms, and applications related to digital medicine; marketing, development, design, manufacture, sale, and after-sales service related to medical robots; and distribution and after sales support of medical devices and reagents for biotechnology, medical technology, and molecular cell analysis. The company serves national and other public hospitals, private hospitals, universities, research institutes, other medical institutions, etc. It also exports its products to approximately 190 countries. Sysmex Corporation has a strategic alliance with QIAGEN N.V. for the development and commercialization of cancer companion diagnostics using Plasma-Safe-SeqS technology. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.